30181002|t|Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature.
30181002|a|BACKGROUND: Although haloperidol is the most widely used drug in the treatment of delirium, evidence on the relevance of atypical antipsychotics (AAPs) is growing. OBJECTIVE: To review the literature on the efficacy and tolerability of AAPs in the treatment of delirium. METHODS: A systematic search of the literature published before April 2018 was performed on PubMed using the following search strings: "Delirium" and "Atypical antipsychotics", "Novel antipsychotics", "New antipsychotics", "Quetiapine", "Olanzapine", "Aripiprazole", "Risperidone", "Paliperidone", "Clozapine", "Asenapine", "Iloperidone", "Amisulpiride", "Ziprasidone", "Zotepine", "Sertindole", "Lurasidone" or "Perospirone". RESULTS: Twelve randomized controlled trials (RCTs) and 22 open trials were considered. Despite an overall lack of large-scale RCTs, there is some evidence supporting the efficacy of olanzapine and quetiapine in placebo controlled trials. In a recent and large RCT in elderly patients, risperidone and/or haloperidol were associated with a significantly worse outcome than placebo. While preliminary, the current comparative studies suggest that haloperidol and the AAPs olanzapine, quetiapine and risperidone are similarly effective, although treatment with AAPs is associated with a reduced incidence of extrapyramidal symptoms. Ziprasidone was not shown to be effective. No RCTs are available for other AAPs. CONCLUSIONS: Although the current evidence of the efficacy and tolerability of AAPs in the treatment of delirium is limited and the heterogeneity of the data precluded a meta-analysis, olanzapine and quetiapine seem to be adequate alternatives to haloperidol, especially in patients who are vulnerable for extrapyramidal symptoms, who require sedation or who have a history of haloperidol intolerance. Evidently, larger-scale RCTs are urgently required.
30181002	29	52	Atypical Antipsychotics	Chemical	-
30181002	73	81	Delirium	Disease	MESH:D003693
30181002	143	154	haloperidol	Chemical	MESH:D006220
30181002	204	212	delirium	Disease	MESH:D003693
30181002	243	266	atypical antipsychotics	Chemical	-
30181002	268	272	AAPs	Chemical	-
30181002	358	362	AAPs	Chemical	-
30181002	383	391	delirium	Disease	MESH:D003693
30181002	529	537	Delirium	Disease	MESH:D003693
30181002	544	567	Atypical antipsychotics	Chemical	-
30181002	617	627	Quetiapine	Chemical	MESH:D000069348
30181002	631	641	Olanzapine	Chemical	MESH:D000077152
30181002	645	657	Aripiprazole	Chemical	MESH:D000068180
30181002	661	672	Risperidone	Chemical	MESH:D018967
30181002	676	688	Paliperidone	Chemical	MESH:D000068882
30181002	692	701	Clozapine	Chemical	MESH:D003024
30181002	705	714	Asenapine	Chemical	MESH:C522667
30181002	718	729	Iloperidone	Chemical	MESH:C081732
30181002	733	745	Amisulpiride	Chemical	-
30181002	749	760	Ziprasidone	Chemical	MESH:C092292
30181002	764	772	Zotepine	Chemical	MESH:C022172
30181002	776	786	Sertindole	Chemical	MESH:C066304
30181002	790	800	Lurasidone	Chemical	MESH:D000069056
30181002	806	817	Perospirone	Chemical	MESH:C065533
30181002	1003	1013	olanzapine	Chemical	MESH:D000077152
30181002	1018	1028	quetiapine	Chemical	MESH:D000069348
30181002	1096	1104	patients	Species	9606
30181002	1106	1117	risperidone	Chemical	MESH:D018967
30181002	1125	1136	haloperidol	Chemical	MESH:D006220
30181002	1266	1277	haloperidol	Chemical	MESH:D006220
30181002	1286	1290	AAPs	Chemical	-
30181002	1291	1301	olanzapine	Chemical	MESH:D000077152
30181002	1303	1313	quetiapine	Chemical	MESH:D000069348
30181002	1318	1329	risperidone	Chemical	MESH:D018967
30181002	1379	1383	AAPs	Chemical	-
30181002	1426	1449	extrapyramidal symptoms	Disease	MESH:D001480
30181002	1451	1462	Ziprasidone	Chemical	MESH:C092292
30181002	1526	1530	AAPs	Chemical	-
30181002	1611	1615	AAPs	Chemical	-
30181002	1636	1644	delirium	Disease	MESH:D003693
30181002	1717	1727	olanzapine	Chemical	MESH:D000077152
30181002	1732	1742	quetiapine	Chemical	MESH:D000069348
30181002	1779	1790	haloperidol	Chemical	MESH:D006220
30181002	1806	1814	patients	Species	9606
30181002	1838	1861	extrapyramidal symptoms	Disease	MESH:D001480
30181002	1909	1920	haloperidol	Chemical	MESH:D006220
30181002	Comparison	MESH:D000069348	MESH:D006220
30181002	Negative_Correlation	MESH:D018967	MESH:D003693
30181002	Negative_Correlation	MESH:D006220	MESH:D003693
30181002	Negative_Correlation	MESH:D000069348	MESH:D003693
30181002	Positive_Correlation	MESH:D000069348	MESH:D001480
30181002	Positive_Correlation	MESH:D018967	MESH:D001480
30181002	Comparison	MESH:D000077152	MESH:D006220
30181002	Negative_Correlation	MESH:D000077152	MESH:D003693
30181002	Positive_Correlation	MESH:D000077152	MESH:D001480
30181002	Positive_Correlation	MESH:D006220	MESH:D001480

